Dr. Friedman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
560 1st Ave
New York, NY 10016Phone+1 212-263-0050
Summary
- Dr. Kent Friedman is a nuclear medicine physician in New York, NY and is affiliated with multiple hospitals in the area, including NYC Health + Hospitals / Bellevue, NYU Langone Orthopedic Hospital, and NYU Langone Hospitals. He received his medical degree from University of Connecticut School of Medicine and has been in practice 16 years. He is experienced in positron emission tomography and positron emission tomography-magnetic resonance imaging.
Education & Training
- Johns Hopkins UniversityResidency, Nuclear Medicine, 2002 - 2003
- University of ConnecticutInternship, Internal Medicine, 2001 - 2002
- Uconn School Of MedicineClass of 2001
Certifications & Licensure
- CT State Medical License 2023 - 2024
- NY State Medical License 2005 - 2024
- American Board of Nuclear Medicine Nuclear Medicine
Awards, Honors, & Recognition
- New York Magazine: Top Doctors Castle Connolly, 2014
- Top Doctors: New York Metro Area Castle Connolly, 2014
Clinical Trials
- PET/MR Assessment of Sipuleucel T Treatment for Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2014 Jan 01
- Study of Combined Ionizing Radiation and Ipilimumab in Metastatic Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2014 Jul 01
Publications & Presentations
PubMed
- 56 citations25-hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy.Zoe A. Stewart, Amanda L. Blackford, Helina Somervell, Kent P. Friedman, Elizabeth Garrett-Mayer
Surgery. 2005-12-01 - 588 citationsRadiotherapy induces responses of lung cancer to CTLA-4 blockadeSilvia C. Formenti, Nils Rudqvist, Encouse B. Golden, Benjamin T. Cooper, Erik Wennerberg
Nature Medicine. 2018-11-05 - 9 citationsAssessment of salivary gland function after 177Lu-PSMA radioligand therapy: Current concepts in imaging and management.Sonia Mahajan, Ravinder K Grewal, Kent P Friedman, Heiko Schöder, Neeta Pandit-Taskar
Translational Oncology. 2022-07-01
Journal Articles
- Radiotherapy Induces Responses of Lung Cancer to CTLA-4 BlockadeAbraham Chachoua, Silvia C Formenti, Benjamin Cooper, Kent Friedman, Sandra Demaria, Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: